Stockscreener 앱 받기
8.42
0.24%
-0.02
시간 외 거래:
8.42
전일 마감가:
$8.44
열려 있는:
$8.41
하루 거래량:
37,066
Relative Volume:
0.50
시가총액:
$485.72M
수익:
$180.46M
순이익/손실:
$20.20M
주가수익비율:
24.28
EPS:
0.3468
순현금흐름:
$16.59M
1주 성능:
+2.06%
1개월 성능:
-3.22%
6개월 성능:
+23.46%
1년 성능:
+34.08%
1일 변동 폭
$8.41
$8.565
1주일 범위
$8.31
$8.60
52주 변동 폭
$6.24
$9.35
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
8.42 | 489.75M | 180.46M | 20.20M | 16.59M | 0.3468 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
121.11 | 49.56B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.86B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.77 | 35.89B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
578.54 | 25.06B | 3.18B | 1.33B | 1.04B | 27.90 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 개시 | The Benchmark Company | Buy |
| 2024-07-03 | 개시 | Stifel | Buy |
| 2018-02-02 | 개시 | Chardan Capital Markets | Buy |
Kamada Ltd 주식(KMDA)의 최신 뉴스
Kamada Announces Successful GMP Manufacturing Audit by Israel's Ministry of Health - Yahoo
KMDA SEC FilingsKamada Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Investment Report: Is Kamada Ltd stock overvalued or fairly priced2026 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Significant Move: Lilach Payorski Invests $80K In Kamada Stock Options - Benzinga
Eran Nir Sees Potential Growth And Acquires $178K In Kamada Stock Options - Benzinga
David Tsur Takes A Bullish Stance, Acquiring $113K Worth Of Kamada Stock Options - Benzinga
Ishay Davidi Expands Holdings With $113K Kamada Stock Options Acquisition - Benzinga
Chaime Orlev At Kamada Secures Company Stock Options: $417K Acquired - Benzinga
Nir Livneh Enhances Portfolio With Kamada Stock Options: $206K Acquired - Benzinga
Benjamin Dekel Takes A Bullish Stance, Acquiring Kamada Stock Options Worth $41K - Benzinga
Leon Recanati Expands Holdings With $115K Kamada Stock Options Acquisition - Benzinga
Assaf Itshayek Sees Potential Growth And Acquires Kamada Stock Options Worth $41K - Benzinga
Hanni Neheman Backs Up Beliefs With A Notable $118K Acquisition In Kamada Stock Options - Benzinga
Karnit Goldwasser At Kamada Secures Company Stock Options: $115K Acquired - Benzinga
Amir London Takes A Bullish Stance, Acquiring $1.56M Worth Of Kamada Stock Options - Benzinga
Boris Gorelik Takes A Bullish Stance, Acquiring Kamada Stock Options Worth $-9K - Benzinga
Kamada (KMDA) VP reports trustee-held stock option grant and return - Stock Titan
Kamada (KMDA) VP awarded options as prior grants are price-adjusted - Stock Titan
Kamada (KMDA) CEO reports trustee-held option grants and cancellations - Stock Titan
Kamada (KMDA) director reports trustee-held option grants and cancellations - Stock Titan
[Form 4] KAMADA LTD Insider Trading Activity - Stock Titan
Director at Kamada (NASDAQ: KMDA) reports trustee-held option awards and price adjustments - Stock Titan
Option awards adjusted for Kamada (KMDA) director after cash dividend - Stock Titan
Kamada (NASDAQ: KMDA) director logs trustee-held option adjustments - Stock Titan
Kamada (KMDA) VP Livneh granted and adjusts trustee-held stock options - Stock Titan
Kamada (KMDA) adjusts CFO stock options following cash dividend move - Stock Titan
Kamada (NASDAQ: KMDA) director reports trustee-held option adjustments - Stock Titan
Kamada (KMDA) VP awarded 15,000 employee stock options in Form 4 - Stock Titan
Kamada (KMDA) director adjusts option awards after cash dividend change - Stock Titan
Kamada (KMDA) VP logs trustee‑held option grants and disposals - Stock Titan
Kamada (KMDA) VP grants and surrenders 112,500 stock options under 2011 plan - Stock Titan
Kamada (KMDA) VP Brenner reports employee option adjustments after dividend - Stock Titan
Stock options for Kamada (KMDA) director adjusted after dividend - Stock Titan
KMDA PE Ratio & Valuation, Is KMDA Overvalued - intellectia.ai
Kamada Ltd Earnings Call Signals Confident Growth Path - The Globe and Mail
Kamada obtains Israeli tax ruling for $14.4M dividend payment By Investing.com - Investing.com South Africa
Kamada (KMDA) Secures Favorable Tax Ruling on Cash Dividend - GuruFocus
Kamada Details Israeli Withholding Terms for April 7 Cash Dividend - TipRanks
Kamada (NASDAQ: KMDA) outlines Israeli tax relief on $0.25 dividend - Stock Titan
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders - ChartMill
Kamada: From Buy To Hold After 22.4% Surge (Rating Downgrade) (NASDAQ:KMDA) - Seeking Alpha
Kamada’s San Antonio plasma center wins FDA approval By Investing.com - Investing.com South Africa
Aug PreEarnings: Can Kamada Ltd continue delivering strong returns2026 Short Interest & Community Trade Idea Sharing - baoquankhu1.vn
Kamada (KMDA) Gains FDA Approval for San Antonio Plasma Center - gurufocus.com
Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas - Bitget
FDA Approves Kamada's (KMDA) Plasma Collection Facility in Texas - GuruFocus
Kamada Wins FDA Nod for High-Capacity San Antonio Plasma Center - TipRanks
Kamada’s San Antonio plasma center wins FDA approval - Investing.com
FDA clears Kamada (NASDAQ: KMDA) San Antonio plasma collection center - Stock Titan
Earnings call transcript: Kamada Ltd. misses Q4 2025 forecasts, stock dips - Investing.com Australia
Earnings call transcript: Kamada Ltd. misses Q4 2025 forecasts, stock dips By Investing.com - Investing.com South Africa
Kamada Ltd (KMDA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.06%
1.05%
자본화:
|
볼륨(24시간):